Cleared Traditional

K913622 - HEMOPLUS

K913622 is an FDA 510(k) clearance for HEMOPLUS, manufactured by Sarstedt, Inc.. The device is a Class 2 Hematology device with product code KHE cleared through the Traditional 510(k) pathway after a 170-day FDA review.

K913622 · Sarstedt, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1992
Decision
170d
Days
Class 2
Risk

K913622 is an FDA 510(k) clearance for the HEMOPLUS. Classified as Reagent, Occult Blood (product code KHE), Class II - Special Controls.

Submitted by Sarstedt, Inc. (Newton, US). The FDA issued a Cleared decision on January 31, 1992 after a review of 170 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.6550 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Sarstedt, Inc. devices

FDA 510(k) Submission Details - K913622

510(k) Number K913622 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 14, 1991
Decision Date January 31, 1992
Days to Decision 170 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
57d slower than avg
Panel avg: 113d · This submission: 170d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KHE Device Classification - Class 2, Special Controls

Product Code KHE Reagent, Occult Blood
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.6550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - KHE Reagent, Occult Blood

All 49
Devices cleared under the same product code (KHE) and FDA review panel - the closest regulatory comparables to K913622.
HEMAPROMPT
K972763 · Aerscher Diagnostics · Oct 1997
FLEXSURE OBT
K961062 · Smithkline Diagnostics, Inc. · Nov 1996
PROPPER SUPER SERACULT(R)
K921798 · Propper Mfg. Co., Inc. · Oct 1992
HEMAWIPE SYSTEM, THE CIVILIZED TEST, MODIFICATION
K912979 · Labeltape Meditect, Inc. · Oct 1991
COLOCARE
K905798 · Helena Laboratories · Jul 1991
COLOSCREEN
K911075 · Helena Laboratories · Jul 1991